Dihydrocodeine Ennogen Ip

Dihydrocodeine Tartrate is an opioid pain reliever used for moderate to severe pain management. This oral medication is manufactured by Ennogen Ip Limited and is available in various strengths.

Dihydrocodeine Tartrate is commonly used for pain relief, particularly for moderate to severe pain that other medications may not adequately address. It is often prescribed for conditions that require strong pain management, such as chronic pain or post-surgical discomfort. The medication works by binding to opioid receptors in the brain, altering the perception of pain.

Common effects of Dihydrocodeine Tartrate may include drowsiness, dizziness, and nausea. Some users may also experience constipation or dry mouth. These effects can vary depending on the individual and the dosage. It is important to monitor how the body responds to the medication and consult a healthcare provider if any adverse effects are experienced.

Dihydrocodeine Tartrate should be handled with care, especially by individuals with a history of substance abuse or respiratory conditions. It is important to follow the prescribed dosage and avoid activities that require alertness, such as driving, until the effects of the medication are known. Pregnant or breastfeeding women should consult a healthcare provider before using this medication.

Dihydrocodeine Tartrate may interact with other medications, including alcohol, sedatives, and certain antidepressants. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Combining this medication with alcohol or other central nervous system depressants can increase the risk of severe side effects.